Raidium Introduces AI Imaging Platform for U.S. Cancer Centers
Raidium announced in a press release the U.S. launch of its AI imaging platform, Raidium Read. The tool is designed to improve oncology imaging workflows by combining multiple radiology functions in one interface. It is already deployed at Moffitt Cancer Center, where it replaces a legacy radiomics solution.
The Raidium Read platform supports whole body lesion detection, AI segmentation models, and lesion tracking across follow up and prior studies. It is initially available for use in oncology research and clinical trials, pending regulatory clearance for routine clinical use.
According to Raidium, the system reduces manual workload, improves consistency in image interpretation, and facilitates collaboration between radiologists and clinicians. The company is pursuing 510(k) clearance for selected features and expects to complete this process by the end of 2026. Cancer centers can register for access through the company's invitation program.
Raidium operates from Paris and Silicon Valley, focusing on integrating foundation models with unified clinical viewers for radiology applications.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice Operations Oct 15 Study Tracks 270 Million Clinical AI Queries on OpenEvidence Oct 15 OpenAI Offers US University Labs Free GPT-Rosalind AccessLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Linearis Joins Two Canadian AI Health Data Projects
Illumina Launches BioInsight Platform for Genomic Research
HOPPR Brings Radiology Foundation Models to CARPL.ai
Brainomix and Pulmonary Fibrosis Foundation Partner on AI Lung Imaging Research
AIRS Medical Gets FDA Clearance for MRI Body Composition Tool
Daily AI Brief: the AI news that matters, in your inbox.